Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference
Quidel Corporation (NASDAQ: QDEL) announced its participation at the William Blair 41st Annual Growth Stock Conference on June 3, 2021. Presenting will be CEO Douglas Bryant and CFO Randy Steward at 10:40 a.m. Central time. The presentation will cover important business trends and developments. A live webcast and audio archive will be accessible via the company’s Investor Relations page. Quidel is a leader in rapid diagnostic solutions, aiming to enhance global healthcare quality.
- None.
- None.
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the William Blair 41st Annual Growth Stock Conference to be held virtually on Thursday, June 3, 2021.
Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present on that day at 10:40 a.m. Central time (8:40 a.m. Pacific time) in a question-and-answer teleconference format. During the presentation, the company will discuss business and financial developments and trends. The company's statements may contain or constitute material information that has not been previously disclosed.
A live webcast and audio archive of the presentation will be available via the Investor Relations section of the company’s website at http://ir.quidel.com or by clicking the link below:
https://wsw.com/webcast/blair58/qdel/1922570
Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the company’s website for 14 days.
About Quidel Corporation
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world. For more information about Quidel, visit quidel.com.
View our story told by our people at www.quidel.com/ourstory
View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005787/en/
FAQ
When will Quidel Corporation present at the William Blair 41st Annual Growth Stock Conference?
Who will present for Quidel Corporation at the conference?
Where can I access the live webcast of Quidel's presentation?
What will Quidel Corporation discuss during the presentation?
How long will the webcast of Quidel's presentation be available?
